Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04322994 · ClinicalTrials.gov registry record · NA
THRIVE Use in Pediatric Populations- Multi Site
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT04322994: Completed NA study, sponsored by Stanford University.
NCT04322994 is a NA study that has completed, run by Stanford University. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04322994, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can prevent desaturation events in children under anesthesia and improve the outcomes of that surgery.
Interventions
- DEVICE Transnasal Humidified Rapid-Insufflation Ventilatory Echange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2020-10-21 |
| Est. Completion | 2024-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04322994
The ClinicalTrials.gov registry entry for NCT04322994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transnasal Humidified Rapid-Insufflation Ventilatory Echange is the first listed.
NCT04322994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04322994 about?
NCT04322994 is a clinical study titled "THRIVE Use in Pediatric Populations- Multi Site". THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedure...
What is the current status of trial NCT04322994?
This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2020-10-21. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT04322994?
The interventions under investigation include: Transnasal Humidified Rapid-Insufflation Ventilatory Echange (DEVICE).
Who is sponsoring clinical trial NCT04322994?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.